Pneumatic Dilation Treatment to Gain Significant Traction in Achalasia Treatment Market 2021 to 2031, Explores Fact.MR Study

The Global Achalasia Treatment Market Study, with both top-down and bottom-up approaches, calculates the  market size of the market as well as forecast the status of various industries in the entire Market. The projection of the market has been presented both in terms of value and volume.

The market study analyzes each market player encompassed in the market study as per its market share, production footprint, current launches, agreements, ongoing R&D projects, and  market strategies. SWOT analysis has been performed in the market study to investigate the strengths, weaknesses, opportunities and threats of each player.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=992

Achalasia Treatment Market: Drivers and Restraints

Increasing research grants and R&D expenditure form governments is driving the growth of the global achalasia treatment market. Rising government support is encouraging the development of treatment options for achalasia and are expected to change the landscape of achalasia treatment over the forecast period (2018-2028). Furthermore, the presence of a small number of affected people is likely to put a severe strain on the healthcare system. Rare disorders are supported by well-organized patient advocacy organizations such as National Organization for Rare Disorders (NORD). However, inadequate treatment information about achalasia among healthcare providers is expected to restrain the global achalasia treatment market. In addition, awareness and understanding of rare disorders such as achalasia are often low and several patients are struggling to find adequate information about it. These factors are also expected to hamper the growth of the global achalasia treatment market.

Achalasia Treatment Market: Segmentation

The global achalasia treatment market has been segmented on the basis of treatment, end user and geography.

Based on treatment, the global achalasia treatment market is segmented as:

  • Non-Surgical Treatment
    • Botulinum toxin type A
    • Pneumatic dilation
    • Others
  • Surgical Treatment
    • Peroral Endoscopic Myotomy (POEM)
    • Heller Myotomy
    • Others

Based on End User, the global achalasia treatment market is segmented as:

  • Hospitals
  • Specialty Clinics
  • Research Institutes

For critical insights on this market, request for methodology here –  https://www.factmr.com/connectus/sample?flag=RM&rep_id=992

Achalasia Treatment Market: Overview

Over the forecast period, achalasia treatment market is expected to witness moderate growth. Approximately 85-90% of achalasia cases can be treated with surgical procedures. During surgical procedures, the muscle fibres in the lower oesophageal sphincter are cut. Among surgical treatment types, the Heller Myotomy segment is expected to lead in the global achalasia treatment market over the forecast period. The hospitals end-user segment is expected to contribute to the maximum market share in the global achalasia treatment market. Achalasia treatment for patients majorly focuses on the improvement of symptoms.

Achalasia Treatment Market: Regional Outlook

Geographically, the global achalasia treatment market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to continue to dominate the global achalasia treatment market owing to the presence of prominent key players and favourable reimbursement scenario in the region. The Asia Pacific achalasia treatment market is expected to grow at a maximum CAGR over the forecast period due to the entry of new players in the region and increasing awareness about achalasia treatment. The Middle East & Africa and Latin America regions are expected to hold a minimum market share in the global achalasia treatment market owing to lack of strategies for access to treatments for achalasia.

Explore Fact.MR’s Comprehensive Coverage on Food & Beverages Landscape

Ice Tea Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/ice-tea-market

Plant-based Fish Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/plant-based-fish-market

Animal Feed Probiotics Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/2891/animal-feed-probiotics-market

Read More Trending Reports of Fact.MR-

http://www.globenewswire.com/en/news-release/2019/10/07/1925890/0/en/Mycoprotein-Products-a-US-200-Million-Market-Will-Be-the-Future-of-Nutritive-Non-Meat-Protein-Finds-Fact-MR.html

Achalasia Treatment Market: Key Players

Some of the key players operating in the global achalasia treatment market are Allergan plc; Ipsen Biopharmaceuticals, Inc.; Nestlé Skin Health (Galderma S.A.); Merz Pharma; Aesculap, Inc. and Silex Medical, LLC.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, Rest Of MEA)

The market report gets rid of the following queries:

  1. Which end use has the highest rate of consumption and why?
  2. Which regions are the market players targeting to gain a competitive edge?
  3. What is the growth forecast of the market in region?
  4. What is the Y-o-Y growth rate of the market?
  5. Which segment will have the maximum share of the market by the end of year?

And so on…..

Ask for TOC here-  https://www.factmr.com/connectus/sample?flag=T&rep_id=992

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Leave a comment

Your email address will not be published. Required fields are marked *